33 related articles for article (PubMed ID: 38448049)
1. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Giakoustidis D; Giouleme O; Papanikolaou V; Akriviadis E; Vasiliadis T
Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122
[TBL] [Abstract][Full Text] [Related]
2. Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins.
Lenci I; Tariciotti L; Angelico R; Milana M; Signorello A; Manzia TM; Toti L; Tisone G; Angelico M; Baiocchi L
Clin Transplant; 2023 Jun; 37(6):e14971. PubMed ID: 36928864
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients.
Cholongitas E; Oikonomou T; Bafa K; Sinakos E; Papatheodoridis GV; Goulis I
Transplantation; 2024 Apr; ():. PubMed ID: 38557857
[TBL] [Abstract][Full Text] [Related]
4. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
Rodríguez-Tajes S; García-Eliz M; Marcos AC; Campos-Varela I; Ros AC; Loinaz C; Gómez Bravo MÁ; Rodríguez-Perálvarez M; Fabrega E; González Diéguez ML; Vinaixa C; Pascasio JM; Vázquez IF; Baliellas C; Castells L; Salcedo M; Prieto M; Crespo G; Lens S; Forns X
Liver Int; 2024 Feb; 44(2):279-285. PubMed ID: 38100141
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin.
Ganbold A; Bayarsaikhan S; Chimedtseren M; Noronrenchin O; Ochirkhuree B
Clin Transplant Res; 2024 Mar; 38(1):46-51. PubMed ID: 38448049
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
Ferenci P; Reiberger T; Stadlbauer V; Zoller H
Liver Int; 2023 Aug; 43 Suppl 1():96-100. PubMed ID: 35767373
[TBL] [Abstract][Full Text] [Related]
7. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts.
Orfanidou A; Papatheodoridis GV; Cholongitas E
Liver Int; 2021 Jul; 41(7):1448-1461. PubMed ID: 33656809
[TBL] [Abstract][Full Text] [Related]
8. The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation.
Battistella S; Zanetto A; Gambato M; Germani G; Senzolo M; Burra P; Russo FP
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243124
[TBL] [Abstract][Full Text] [Related]
9. Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation.
Zignego AL; Samuel D; Gentilini P; Bismuth H
Arch Virol Suppl; 1993; 8():281-9. PubMed ID: 8260873
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
Cholongitas E; Goulis J; Akriviadis E; Papatheodoridis GV
Liver Transpl; 2011 Oct; 17(10):1176-90. PubMed ID: 21656655
[TBL] [Abstract][Full Text] [Related]
11. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.
Cholongitas E; Papatheodoridis GV
Am J Transplant; 2013 Feb; 13(2):353-62. PubMed ID: 23137006
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]